China’s AI sector in May and June 2026 was defined by velocity and the public-market race. The country’s leading labs are raising billions privately while simultaneously preparing Hong Kong listings — a dual sprint for capital and sovereignty.

The front-rank labs

The dynamics that matter

1. Valuations are compounding fast. Moonshot went from $4.3B in late 2024 to a sought-after $30B — a 7x leap in 18 months — on the back of its Kimi chatbot and K2.5-powered Kimi Work agent.
2. Hong Kong is the chosen exit. StepFun filed to raise ~$500M at a $12B valuation, joining a wave of Chinese AI labs (Zhipu, MiniMax) listing domestically rather than in the U.S. — a strategic shift away from American capital markets.
3. Embodied AI cooled but didn’t collapse. Embodied-intelligence funding fell nearly 60% month-over-month in May to 8.6B yuan, signaling a shift to more selective, specialized capital — though annual totals remain well above prior years.

The open question

The bottleneck isn’t raising capital — it’s converting valuation into durable revenue before U.S. chip export controls or domestic competition reshape the race. A $30B private mark is a bet that China’s leaders can.

Practical takeaway (operator + investor)

For global investors, China’s AI cohort is increasingly walled off but formidable — funded by Meituan, state-backed vehicles, and self-reliance capital. Watch the Hong Kong IPO pipeline as the clearest read on which labs can sustain their valuations.

Sources

1. Tech Funding News (Moonshot AI $30B): https://techfundingnews.com/chinas-moonshot-ai-reportedly-seeks-up-to-2b-at-30b-valuation-as-race-to-challenge-openai-intensifies/
2. Asia Tech Review (StepFun infrastructure & IPO): https://www.asiatechreview.com/p/infrastructure-specialist-stepfun
3. Gate News (StepFun HK IPO filing at $12B): https://www.gate.com/news/detail/ai-startup-stepfun-submits-hong-kong-ipo-application-today-valued-at-12-21717686